Treatment of patients with primary Sjogren's syndrome with rituximab is efficient according to the EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI)

被引：0
|
作者：
Vissink, A. [1 ]
Moerman, R. V. [2 ]
Arends, S. [2 ]
Meiners, P. M. [1 ]
Meijer, J. M. [1 ]
Kroese, F. G. M. [2 ]
Spijkervet, F. K. L. [1 ]
Bootsma, H. [2 ]
机构：
[1] Univ Groningen, Dept Oral & Maxillofacial Surg, Univ Med Ctr Groningen, Groningen, Netherlands
[2] Univ Groningen, Dept Rheumatol & Clin Immunol, Univ Med Ctr Groningen, Groningen, Netherlands
来源：
ORAL DISEASES | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [41] Is rituximab a promising treatment for Sjogren's syndrome?
    Devauchelle-Pensec, V.
    Pers, J. O.
    Youinou, P.
    Saraux, A.
    REVUE DE MEDECINE INTERNE, 2008, 29 (12): : 967 - 970
  • [42] Successful treatment of Sjogren's syndrome with rituximab
    Touma, Z.
    Sayad, J.
    Arayssi, T.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (04) : 323 - 325
  • [43] Assessment of EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) Domains in Routine Clinical Practice in an Integrated Delivery Network in the United States
    Ndife, Briana
    Pivneva, Irina
    Rossi, Carmine
    Signorovitch, James
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 642 - 645
  • [44] Treatment of Primary Sjogren Syndrome With Rituximab
    Faustman, Denise L.
    Vivino, Frederick B.
    Carsons, Steven E.
    ANNALS OF INTERNAL MEDICINE, 2014, 161 (05) : 376 - 377
  • [45] Sjogren's Syndrome Mortality in primary Sjogren's Syndrome
    Ruchalla, Elke
    AKTUELLE RHEUMATOLOGIE, 2016, 41 (04) : 279 - 279
  • [46] The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients
    Cho, Hyon Joung
    Yoo, Jong Jin
    Yun, Chan Young
    Kang, Eun Ha
    Lee, Hyo-Jung
    Hyon, Joon Young
    Song, Yeong Wook
    Lee, Yun Jong
    RHEUMATOLOGY, 2013, 52 (12) : 2208 - 2217
  • [47] European League Against Rheumatism Sjogren's Syndrome Disease Activity Index and European League Against Rheumatism Sjogren's Syndrome Patient-Reported Index: A Complete Picture of Primary Sjogren's Syndrome Patients
    Seror, R.
    Gottenberg, J. E.
    Devauchelle-Pensec, V.
    Dubost, J. J.
    Le Guern, V.
    Hayem, G.
    Fauchais, A. -L.
    Goeb, V.
    Hachulla, E.
    Hatron, P. Y.
    Larroche, C.
    Morel, J.
    Pedriger, A.
    Puechal, X.
    Rist, S.
    Saraux, A.
    Sene, D.
    Sibilia, J.
    Vittecoq, O.
    Zarnitsky, C.
    Labetoulle, M.
    Ravaud, P.
    Mariette, X.
    ARTHRITIS CARE & RESEARCH, 2013, 65 (08) : 1358 - 1364
  • [48] SJOGREN SYNDROME: EVALUATION OF THE DISEASE ACTIVITY USING THE ESSDAI IN 70 PATIENTS
    Dinis De Freitas, J.
    Costa, F.
    Brites, L.
    Rovisco, J.
    Ines, L.
    Malcata, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S51 - S51
  • [49] Correlation between sleeping quality with fatigue, quality of life and disease activity (ESSDAI) in patients with primary Sjogren's syndrome
    Dardin, Luciana Paula
    Andreo Garcia, Ana Beatriz
    Diniz Adan, Consuelo Bueno
    dos Santos, Fania Cristina
    de Mello, Marco Tulio
    Moca Trevisani, Virginia Fernandes
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S318 - S318
  • [50] VARIATION IN SYSTEMIC DISEASE ACTIVITY MEASURED WITH ESSDAI IN A PROSPECTIVE LONGITUDINAL COHORT OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME WITHOUT IMMUNOSUPPRESSIVE TREATMENT
    De Wolff, L.
    Verstappen, G. M.
    Stel, A. J.
    Van Zuiden, G. S.
    Van Nimwegen, J. F.
    Vissink, A.
    Kroese, F. G. M.
    Arends, S.
    Bootsma, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1076 - 1077
12345